Therefore, both RRMS and MG patients have increased numbers of pro-inflammatory T-helper 1 (Th1) and Th17 cells along with their associated pro-inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-17, interferon-γ, and tumor necrosis factor alpha (TNF-α) [1,15]. Here, TNF is linked to myasthenia gravis.